X-ZELL selected as finalist for prestigious Hello Tomorrow Singapore Challenge Singapore, October 2019 – X-ZELL has been nominated as one of 16 regional finalists of the 2019 Hello Tomorrow Singapore Challenge. Hello Tomorrow is a global non-profit organisation on a...
X-ZELL technology on show at SWITCH X SSF 2019 Singapore, October 2019 – X-ZELL has been selected as one of the start-ups to be featured on A*ccelerate Technologies’ Innovation Pavilion at the upcoming SWITCH exhibition in Singapore. Short for Singapore Week of...
X-ZELL secures investment by German industrial services powerhouse, DIAG Singapore/ Essen, October 2019 – German industrial services specialist, Deutsche Industrieanlagen (DIAG), has officially joined X-ZELL’s US$3m Seed+ funding round. Ranked amongst Asia’s 50 most...
X-ZELL ranked among Top 50 health tech start-ups in Asia Singapore, October 2019 – X-ZELL has been ranked amongst the 50 leading health tech start-ups in Asia for the second year running. Every year, the prestigious list is compiled by Singapore-based analytics and...
New test capable of detecting clinically significant prostate cancer in small blood sample Bangkok/Basel, August 2019 (via PR Newswire) – An international research team at Mahidol University in Bangkok, Thailand, has demonstrated the potential for a new blood test to...
X-ZELL to launch AI-powered cell analysis project Singapore, July 2019 – Singapore-based rare cell detection specialist, X-ZELL, is about to embark on the most ambitious research and innovation project in the company’s history. Nicknamed Cloud Atlas, the landmark...
